Last reviewed · How we verify

NCT06949696

Effect of Dual-Task Training and Cognitive Rehabilitation in Individuals With Multiple Sclerosis.

Recruiting now NA Last updated 29 April 2025
What this trial tests

NA trial testing Dual Task Training in Multiple Sclerosis in 30 participants. Currently enrolling.

Timeline
20 April 2025
Primary endpoint
30 June 2025
1 June 2026

Quick facts

Lead sponsorToros University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment30
Start date20 April 2025
Primary completion30 June 2025
Estimated completion1 June 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Toros University

Who can join

Adults 18 to 65, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to examine the effects of dual-task training and cognitive rehabilitation on gait, balance, fatigue and cognitive performance in individuals with multiple sclerosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dual Task Training

Trials testing the same drug.

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other Toros University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06949696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing